Meta-analysis: Risk of pancreatic cancer in patients with inflammatory bowel disease.

Mohammad ZamaniShaghayegh Alizadeh-TabariMohammad Hassan MuradAshwin N Ananthakrishnan Fatemeh Malekzadeh Nicholas J Talley

Published in: Alimentary pharmacology & therapeutics (2024)

Our results suggest a moderate increase in the risk of pancreatic cancer in patients with IBD, which may be further heightened by genetic predisposition to IBD. The increased risk of pancreatic cancer is probably similar in Crohn's disease and ulcerative colitis.

Keyphrases

ulcerative colitis
patients with inflammatory bowel disease
systematic review
meta analyses
high intensity
gene expression
dna methylation